Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Deferred Taxes (2022 - 2025)

Historic Deferred Taxes for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to $246000.0.

  • GeneDx Holdings' Deferred Taxes rose 62340.43% to $246000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424000.0, marking a year-over-year increase of 15808.22%. This contributed to the annual value of -$343000.0 for FY2024, which is 6295.9% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Deferred Taxes is $246000.0, which was up 62340.43% from -$245000.0 recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Deferred Taxes ranged from a high of $447000.0 in Q1 2025 and a low of -$49.1 million during Q2 2022
  • Moreover, its 4-year median value for Deferred Taxes was -$123000.0 (2022), whereas its average is -$3.6 million.
  • As far as peak fluctuations go, GeneDx Holdings' Deferred Taxes tumbled by 89038.46% in 2023, and later soared by 64512.2% in 2025.
  • Quarter analysis of 4 years shows GeneDx Holdings' Deferred Taxes stood at $52000.0 in 2022, then tumbled by 890.38% to -$411000.0 in 2023, then soared by 94.16% to -$24000.0 in 2024, then skyrocketed by 1125.0% to $246000.0 in 2025.
  • Its last three reported values are $246000.0 in Q3 2025, -$245000.0 for Q2 2025, and $447000.0 during Q1 2025.